PCSK9 inhibitors for prevention of cardiovascular disease – Cochrane Library
3 May, 2017 | 17:28h | UTCSystematic review: PCSK9 inhibitors for prevention of cardiovascular disease – Cochrane Library (free summary – $ for full-text))
The evidence so far suggests that PCSK9 inhibitor use probably leads to little or no difference in mortality and leads to a modest absolute risk reduction (often less than 1%) in cardiovascular events in high-risk patients.